About AGILeBiotics
AGILeBiotics is a Healthcare company based in Groningen (Netherlands) founded in 2017 by Andreas A Bastian. Antibiotics for MDR infections are developed via proprietary OxaSelect platform. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified.
Company details
AGILeBiotics was founded in 2017 as a spin-off from the University of Groningen in the Netherlands. The company operates in the biotechnology sector, focusing on antibiotics to combat multi-drug resistant infections. A proprietary OxaSelect technology is utilized to modify existing antibiotics through site-selective processes, enabling the creation of a library of candidates derived from complex natural products that address bacterial resistance mechanisms.
- Headquarters Groningen, Netherlands
- Founders Andreas A Bastian
- SectorsHealthcare
- Phone•••• ••••
- Website agilebiotics.com
- Investors
Funding Insights of AGILeBiotics
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of AGILeBiotics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2018 | Seed | – | – |
1 investors in total: 1 institutional.
Investors in AGILeBiotics
AGILeBiotics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Carduso Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investments are made in science-driven businesses. | cardusocapital.com | Groningen, Netherlands |
Investor details for AGILeBiotics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of AGILeBiotics
1 people are tracked at AGILeBiotics (1 in leadership).
| Name | Role | Group |
|---|---|---|
Andreas A Bastian | Co-Founder | Leadership |
Complete people profiles for AGILeBiotics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of AGILeBiotics
2 dated milestones of AGILeBiotics across 1 years, from founding to its latest funding, stage changes and deals.
- Founded AGILeBiotics is founded.
- Funding First funding round.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about AGILeBiotics
AGILeBiotics was founded in 2017 and raised its 1st funding round 1 year after it was founded.
AGILeBiotics is headquartered in Groningen, Netherlands. It is registered at Groningen, Groningen, Netherlands.
AGILeBiotics was founded in 2017 as a spin-off from the University of Groningen in the Netherlands. The company operates in the biotechnology sector, focusing on antibiotics to combat multi-drug resistant infections. A proprietary OxaSelect technology is utilized to modify existing antibiotics through site-selective processes, enabling the creation of a library of candidates derived from complex natural products that address bacterial resistance mechanisms.
AGILeBiotics has 1 investor. Key investors include Carduso Capital.